Sudarshan Pharma Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 143.73 | 162.48 | 116.10 |
| Operating Expense | 132.03 | 148.01 | 108.14 |
| Net Profit | 3.73 | 7.03 | 2.93 |
| Net Profit Margin | 2.60 | 4.33 | 2.52 |
| Earning Per Share | 0.15 | 0.29 | 0.12 |
| EBIDTA | 11.40 | 14.77 | 7.58 |
| Effective Tax Rate | 10 | 17.55 | 10.30 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 143.73 |
| Operating Expense | 132.03 |
| Net Profit | 3.73 |
| Net Profit Margin | 2.60 |
| Earning Per Share | 0.15 |
| EBIDTA | 11.40 |
| Effective Tax Rate | 10.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 502.51 | 465.56 | 461.33 |
| Operating Expenses Annual | 464.00 | 442.96 | 446.64 |
| Operating Profit Annual | 38.56 | 25.36 | 15.81 |
| Interest Annual | 15.96 | 9.03 | 5.40 |
| Depreciation | 1.31 | 1.23 | 0.91 |
| Net Profit Annual | 15.88 | 11.36 | 7.04 |
| Tax Annual | 5.41 | 3.74 | 2.46 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 502.51 |
| Operating Expenses Annual | 464.00 |
| Operating Profit Annual | 38.56 |
| Interest Annual | 15.96 |
| Depreciation | 1.31 |
| Net Profit Annual | 15.88 |
| Tax Annual | 5.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.13 | 11.71 | 0.23 |
| Cash Flow from Operations | 34.91 | 9.69 | -28.79 |
| Cash Flow from Investing | -20.24 | -9.08 | -25.65 |
| Cash Flow from Financing | -14.41 | -12.18 | 65.93 |
| Cash Flow at the End | 0.39 | 0.13 | 11.71 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.13 |
| Cash Flow from Operations | 34.91 |
| Cash Flow from Investing | -20.24 |
| Cash Flow from Financing | -14.41 |
| Cash Flow at the End | 0.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 8.23 | 5.45 | 3.43 |
| PBIT Margin (%) | 7.97 | 5.18 | 3.23 |
| PBT Margin (%) | 7.47 | 4.61 | 2.63 |
| Net PROFIT Margin (%) | 3.16 | 2.44 | 1.53 |
| Return On Networth / Equity (%) | 14.79 | 10.69 | 10.77 |
| Return On Networth /Employed (%) | 15.30 | 13.63 | 15.24 |
| Return On Assets (%) | 6.07 | 6.42 | 7.20 |
| Total Debt / Equity (X) | 1.15 | 0.66 | 0.49 |
| Asset Turnover Ratio (%) | 1.92 | 2.63 | 4.72 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 8.23 |
| PBIT Margin (%) | 7.97 |
| PBT Margin (%) | 7.47 |
| Net PROFIT Margin (%) | 3.16 |
| Return On Networth / Equity (%) | 14.79 |
| Return On Networth /Employed (%) | 15.30 |
| Return On Assets (%) | 6.07 |
| Total Debt / Equity (X) | 1.15 |
| Asset Turnover Ratio (%) | 1.92 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 19.79 | 20.57 | 19.89 |
| Total Current Assets Annual | 333.83 | 240.85 | 198.51 |
| Non Current Assets Annual | 66.57 | 43.99 | 33.96 |
| Total Shareholders Funds Annual | 131.31 | 111.62 | 100.98 |
| Total Assets Annual | 400.40 | 284.84 | 232.47 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 19.79 |
| Total Current Assets Annual | 333.83 |
| Non Current Assets Annual | 66.57 |
| Total Shareholders Funds Annual | 131.31 |
| Total Assets Annual | 400.40 |
EPS (INR)
Expected
0.16
Reported
0.16
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
